Precision for Medicine Webinars and Videos

  1. AI And Multi-Omics For Translational Research 1/20/2026

    Explore the innovations driving drug discovery breakthroughs and shaping future-ready strategies.

  2. 3 FDA Approvals In 2025 That Shift The Landscape For 2026 1/20/2026

    In this presentation, Precision’s Chief Medical Officer and former FDA Director, Division of Oncology 2, Harpreet Singh, MD breaks down 3 FDA approvals from last year that are impacting 2026.

  3. Breaking Barriers With PCR: Innovative Solutions For Clinical Trial Success 9/3/2025

    This presentation brings together experts from Precision for Medicine, Avidity Biosciences, and Indaptus Therapeutics to examine the expanding role of PCR-based molecular monitoring.

  4. Beyond The Data Deluge: Immune Profiling In Early Immuno-Oncology Trials 8/14/2025

    This presentation explores how to design effective immune monitoring for early-phase immuno-oncology trials, focusing on strategic platform selection, cost, and operational feasibility.

  5. The 3 FDA Oncology Approvals That Will Have The Biggest Impact In 2025 7/25/2025

    The FDA wrapped up 2024 with 3 notable approvals. Harpreet Singh, MD and CMO, provides a recap.

  6. The FDA's New Guidance May Be Shaking Up Biotech 7/25/2025

    The FDA’s recent draft guidance on accelerated approval outlines tougher standards for confirmatory trials and introduces a faster process for withdrawing approvals.

  7. Precision In, Precision Out: Elevated Kitting Strategies For Clinical Trials 6/17/2025

    As biomarker-driven clinical trials become increasingly complex, the design and management of clinical trial kits play a pivotal role in ensuring operational success and scientific integrity.

  8. Achieving Regulatory Compliance With A Unified Immunogenicity Strategy 5/10/2025

    This presentation equips viewers with the knowledge and tools needed to navigate the intricacies of designing immunogenicity assays that comply with both European IVDR and US FDA regulations.

  9. Illuminating IHC: Right-Sizing Your Validation And Regulatory Strategy 5/2/2025

    In this presentation, expert speakers provide an in-depth exploration of the essential validation and regulatory strategies for Immunohistochemistry (IHC).

  10. Illuminating IHC: From Biomarker To Clinical Trial Assay 5/2/2025

    Through this presentation, Immunohistochemistry (IHC) expert equip you with the knowledge needed to effectively utilize IHC in your research and clinical practice.